Efficacy and Safety of Percutaneous Radiofrequency Thermal Ablation in the Treatment of Lung Cancer Lesions

Detalhes bibliográficos
Autor(a) principal: Tavares eCastro, Ana
Data de Publicação: 2015
Outros Autores: Freitas, Sara, Portilha, Antónia, Alves, Fernando, Caseiro-Alves, Filipe
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620
Resumo: Introduction: In this study, we reviewed a clinical series composed by all malignant lung lesions submitted to computed tomographyguided percutaneous thermal radiofrequency ablation, in our hospital, a rather recent technique that has been gaining scientific recognition.Material and Methods: For data purposes, all radiofrequency ablation and corresponding clinical records were retrospectivelyanalysed. A computed tomography scan was performed before and after each procedure to evaluate the tumour’s features, and at a second step to assess results and complications. The frequency of local recurrence and disease progression were determined based on imaging follow-up. Kaplan–Meier analysis was used to estimate survival. Univariate analysis recognized clinical and pathological factors affecting survival. These were also tested by multivariate analysis.Results: A total of 28 malignant lung lesions, 20 primary and 8 metastatic, from 28 patients (78.6% male; mean age 62 ± 17 years old), were submitted to computed tomography-guided radiofrequency ablation between January 2004 and July 2010. Total necrosis was achieved in 74.1% of the lesions. Immediate radiofrequency ablation-related complications were observed in half of the procedures. Among major complications, death occurred in one patient only. Median overall survival was 43.0 months for a mean 2-years follow-up.Median progression-free survival was 31.6 months. Lesion’s size smaller than 35 mm, stage III disease by the TNM classification and previous treatment attempts were significantly associated with better outcomes. Disease-related mortality was 46.4%.Discussion: This procedure proved to be efficient to treat lung cancerous lesions, with a low-rate of major complications.Conclusions: Computed tomography-guided percutaneous radiofrequency ablation is a minimally invasive procedure that appears to be valuable in the treatment of lung cancer lesions.Keywords: Catheter Ablation; Lung Neoplasms; Tomography, X-Ray Computed.
id RCAP_a46d543b05107a5873507fe96b53e42f
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/5620
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Efficacy and Safety of Percutaneous Radiofrequency Thermal Ablation in the Treatment of Lung Cancer LesionsEficácia e Segurança da Termoablação Percutânea por Radiofrequência no Tratamento das Lesões Cancerígenas PulmonaresIntroduction: In this study, we reviewed a clinical series composed by all malignant lung lesions submitted to computed tomographyguided percutaneous thermal radiofrequency ablation, in our hospital, a rather recent technique that has been gaining scientific recognition.Material and Methods: For data purposes, all radiofrequency ablation and corresponding clinical records were retrospectivelyanalysed. A computed tomography scan was performed before and after each procedure to evaluate the tumour’s features, and at a second step to assess results and complications. The frequency of local recurrence and disease progression were determined based on imaging follow-up. Kaplan–Meier analysis was used to estimate survival. Univariate analysis recognized clinical and pathological factors affecting survival. These were also tested by multivariate analysis.Results: A total of 28 malignant lung lesions, 20 primary and 8 metastatic, from 28 patients (78.6% male; mean age 62 ± 17 years old), were submitted to computed tomography-guided radiofrequency ablation between January 2004 and July 2010. Total necrosis was achieved in 74.1% of the lesions. Immediate radiofrequency ablation-related complications were observed in half of the procedures. Among major complications, death occurred in one patient only. Median overall survival was 43.0 months for a mean 2-years follow-up.Median progression-free survival was 31.6 months. Lesion’s size smaller than 35 mm, stage III disease by the TNM classification and previous treatment attempts were significantly associated with better outcomes. Disease-related mortality was 46.4%.Discussion: This procedure proved to be efficient to treat lung cancerous lesions, with a low-rate of major complications.Conclusions: Computed tomography-guided percutaneous radiofrequency ablation is a minimally invasive procedure that appears to be valuable in the treatment of lung cancer lesions.Keywords: Catheter Ablation; Lung Neoplasms; Tomography, X-Ray Computed.Introdução: Neste estudo foram caracterizados e avaliados todos os tumores malignos do pulmão no nosso hospital submetidos a termoablação percutânea por radiofrequência guiada por tomografia computadorizada, uma técnica relativamente recente com crescente evidência científica.Material e Métodos: Os registos clínicos referentes a todas as termoablações percutâneas por radiofrequência realizadas na nossa instituição foram retrospectivamente analisados. Realizou-se uma tomografia computadorizada antes e depois de cada procedimento para avaliar as características do tumor e, numa segunda fase, para avaliar os resultados e complicações. A recorrência e progressão da doença foram determinados através do seguimento imagiológico. A análise Kaplan-Meier foi usada para calcular a sobrevivência. A análise univariada identificou os fatores clínicos e patológicos que afetaram a sobrevivência.Resultados: Um total de 28 lesões pulmonares malignas, 20 carcinomas primários e oito lesões metastáticas, de 28 doentes (78,6% do género masculino, com idade média de 62 ± 17 anos), foram submetidos a termoablação percutânea por radiofrequência entre janeiro de 2004 e julho de 2010. Obteve-se necrose total em 74,1% das lesões. Observaram-se complicações imediatas em metade dos procedimentos. Das principais complicações, ocorreu a morte em apenas um doente. A sobrevivência mediana global foi de 43,0 meses para uma média de dois anos de acompanhamento. A sobrevivência mediana sem progressão da doença foi de 31,6 meses. Osfatores que mostraram correlação estatisticamente significativa com melhores resultados foram: tamanho da lesão menor que 35 mm, doença no estádio III da classificação TNM e realização de tratamentos prévios. A mortalidade por progressão da doença foi de 46,4%.Discussão: Este procedimento provou ser eficaz no tratamento de lesões pulmonares cancerígenas, com uma baixa incidência de complicações graves.Conclusões: A termoablação percutânea por radiofrequência é um procedimento minimamente invasivo, que aparenta ser vantajoso no tratamento de lesões cancerígenas do pulmão.Palavras-chave: Ablação por Cateter; Neoplasias do Pulmão; Tomografia Computorizada.Ordem dos Médicos2015-02-27info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620oai:ojs.www.actamedicaportuguesa.com:article/5620Acta Médica Portuguesa; Vol. 28 No. 1 (2015): January-February; 63-69Acta Médica Portuguesa; Vol. 28 N.º 1 (2015): Janeiro-Fevereiro; 63-691646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620/4238https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620/7479https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620/7480https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620/7540https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620/7591Tavares eCastro, AnaFreitas, SaraPortilha, AntóniaAlves, FernandoCaseiro-Alves, Filipeinfo:eu-repo/semantics/openAccess2022-12-20T11:04:25Zoai:ojs.www.actamedicaportuguesa.com:article/5620Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:19:08.290880Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Efficacy and Safety of Percutaneous Radiofrequency Thermal Ablation in the Treatment of Lung Cancer Lesions
Eficácia e Segurança da Termoablação Percutânea por Radiofrequência no Tratamento das Lesões Cancerígenas Pulmonares
title Efficacy and Safety of Percutaneous Radiofrequency Thermal Ablation in the Treatment of Lung Cancer Lesions
spellingShingle Efficacy and Safety of Percutaneous Radiofrequency Thermal Ablation in the Treatment of Lung Cancer Lesions
Tavares eCastro, Ana
title_short Efficacy and Safety of Percutaneous Radiofrequency Thermal Ablation in the Treatment of Lung Cancer Lesions
title_full Efficacy and Safety of Percutaneous Radiofrequency Thermal Ablation in the Treatment of Lung Cancer Lesions
title_fullStr Efficacy and Safety of Percutaneous Radiofrequency Thermal Ablation in the Treatment of Lung Cancer Lesions
title_full_unstemmed Efficacy and Safety of Percutaneous Radiofrequency Thermal Ablation in the Treatment of Lung Cancer Lesions
title_sort Efficacy and Safety of Percutaneous Radiofrequency Thermal Ablation in the Treatment of Lung Cancer Lesions
author Tavares eCastro, Ana
author_facet Tavares eCastro, Ana
Freitas, Sara
Portilha, Antónia
Alves, Fernando
Caseiro-Alves, Filipe
author_role author
author2 Freitas, Sara
Portilha, Antónia
Alves, Fernando
Caseiro-Alves, Filipe
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Tavares eCastro, Ana
Freitas, Sara
Portilha, Antónia
Alves, Fernando
Caseiro-Alves, Filipe
description Introduction: In this study, we reviewed a clinical series composed by all malignant lung lesions submitted to computed tomographyguided percutaneous thermal radiofrequency ablation, in our hospital, a rather recent technique that has been gaining scientific recognition.Material and Methods: For data purposes, all radiofrequency ablation and corresponding clinical records were retrospectivelyanalysed. A computed tomography scan was performed before and after each procedure to evaluate the tumour’s features, and at a second step to assess results and complications. The frequency of local recurrence and disease progression were determined based on imaging follow-up. Kaplan–Meier analysis was used to estimate survival. Univariate analysis recognized clinical and pathological factors affecting survival. These were also tested by multivariate analysis.Results: A total of 28 malignant lung lesions, 20 primary and 8 metastatic, from 28 patients (78.6% male; mean age 62 ± 17 years old), were submitted to computed tomography-guided radiofrequency ablation between January 2004 and July 2010. Total necrosis was achieved in 74.1% of the lesions. Immediate radiofrequency ablation-related complications were observed in half of the procedures. Among major complications, death occurred in one patient only. Median overall survival was 43.0 months for a mean 2-years follow-up.Median progression-free survival was 31.6 months. Lesion’s size smaller than 35 mm, stage III disease by the TNM classification and previous treatment attempts were significantly associated with better outcomes. Disease-related mortality was 46.4%.Discussion: This procedure proved to be efficient to treat lung cancerous lesions, with a low-rate of major complications.Conclusions: Computed tomography-guided percutaneous radiofrequency ablation is a minimally invasive procedure that appears to be valuable in the treatment of lung cancer lesions.Keywords: Catheter Ablation; Lung Neoplasms; Tomography, X-Ray Computed.
publishDate 2015
dc.date.none.fl_str_mv 2015-02-27
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620
oai:ojs.www.actamedicaportuguesa.com:article/5620
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/5620
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620/4238
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620/7479
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620/7480
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620/7540
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5620/7591
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 28 No. 1 (2015): January-February; 63-69
Acta Médica Portuguesa; Vol. 28 N.º 1 (2015): Janeiro-Fevereiro; 63-69
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130642340904960